Clinical trial

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive…

NCT00081848 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00081848
Title Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
Official title A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults With CEA Positive Solid Tumors
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Liver Neoplasms
Intervention type Drug
Interventions rV-CEA(6D)/TRICOM-rF-CEA(6D)/TRICOM, rF-CEA(6D)/TRICOM, Recombinant Fowlpox-GM-CSF, Celecoxib
Enrollment 12
Start date Apr 20, 2004
Primary completion Aug 23, 2007
Completion Aug 23, 2007
First posted Apr 22, 2004
Last update posted Jul 2, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies